| P2093 | author name string | Yanan Zhang | |
| | Zhigang Guo | |
| | Tongwei Wu | |
| | Jichen Liu | |
| | Wenyan Lai | |
| | Zhongzhou Guo | |
| | Yusheng Ma | |
| P2860 | cites work | Profound block in thymocyte development in mice lacking p56lck | Q24298882 |
| | Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation | Q28288372 |
| | Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr-/- mice | Q30405805 |
| | Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. | Q33907760 |
| | Lck protein tyrosine kinase is a key regulator of T-cell activation and a target for signal intervention by Herpesvirus saimiri and other viral gene products | Q33940330 |
| | Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis | Q34537191 |
| | Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice | Q35103567 |
| | Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. | Q35640438 |
| | Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL. | Q36197563 |
| | T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. | Q36693820 |
| | Infectious tolerance via the consumption of essential amino acids and mTOR signaling | Q37246191 |
| | The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice | Q37372718 |
| | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 |
| | The isolation and characterization of murine macrophages | Q39485692 |
| | The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment | Q42593305 |
| | Sirolimus for the Prevention of In-Stent Restenosis in a Coronary Artery | Q44605351 |
| | New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice | Q45876621 |
| | Monocyte-Macrophages and T Cells in Atherosclerosis | Q47632654 |
| | Lck Inhibits Heat Shock Protein 65-Mediated Reverse Cholesterol Transport in T Cells. | Q48300814 |
| | Regulatory T cells as a new therapeutic target for atherosclerosis. | Q50093330 |
| | Immune-inflammatory responses in atherosclerosis: Role of an adaptive immunity mainly driven by T and B cells. | Q51719990 |
| | Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. | Q53591929 |
| | Serum amyloid P component therapeutically attenuates atherosclerosis in mice via its effects on macrophages. | Q55311460 |
| | Inflammation in atherosclerosis | Q57295305 |
| | Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 |
| | Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 |
| | Lymphocytes in atherosclerosis | Q84078750 |
| | Heat shock protein 65 promotes atherosclerosis through impairing the properties of high density lipoprotein | Q86156924 |
| | ZAP70 deficiency promotes reverse cholesterol transport through MAPK/ERK pathway in Jurkat cell | Q91030393 |
| P921 | main subject | cell differentiation | Q210861 |
| P304 | page(s) | 87-97 | |
| P577 | publication date | 2020-01-21 | |
| P1433 | published in | Journal of Molecular and Cellular Cardiology | Q2061932 |
| P1476 | title | LCK inhibitor attenuates atherosclerosis in ApoE-/- mice via regulating T cell differentiation and reverse cholesterol transport | |
| P478 | volume | 139 | |